VivoSeq
Other

Trial

0

Pipeline Programs↗

132

Active Trials↗

109

Companies Involved↗

Trial is an early-stage landscape with 0 programs across 109 companies. The most active players are Novo Nordisk, Boehringer Ingelheim, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

63/100

Pipeline Velocity

63/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novo Nordisk logo

Novo Nordisk

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

817

clinical trials

Completed512 · 63%
Unknown status72 · 9%
Recruiting67 · 8%
Terminated62 · 8%
Active, not recruiting35 · 4%
Withdrawn34 · 4%
Other35 · 4%

Clinical Trials

Trial Activity

817 trials

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
Recruiting·MMultiple Myeloma Research Consortium·Phase 2·NCT06171685·300 enrolled
First-in-Human Trial of Oral AN2-502998
Recruiting·AAN2 Therapeutics, Inc·Phase 1·NCT07024589·72 enrolled
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Recruiting·CCanadian Cancer Trials Group·Phase 2·NCT03297606·720 enrolled
Trial of JMKX003801 in Healthy Participants
Recruiting·JJemincare·Phase 1·NCT06549309·70 enrolled
A Trial of Varenicline for E-cigarette Cessation
Recruiting·YYale University·Phase 2·NCT07040566·326 enrolled
MIVetsCan: Cannabidiol (CBD)-Care Trial
Recruiting·—·Phase 2·NCT06213233·468 enrolled
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Recruiting·IImperial College London·Phase 2·NCT04319367·72 enrolled
RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
Recruiting·UUniversity of Utah·Phase 2·NCT05292209·78 enrolled
SWIFT - SWIss Factor XIII Trial in PPH
Recruiting·—·Phase 4·NCT06481995·988 enrolled
SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
Recruiting·UUniversity of Pennsylvania·Phase 2·NCT05138575·53 enrolled
Activated CHARcoal in Poisoned Patient - Pilot Trial
Recruiting·LLaval University·Phase 4·NCT05471479·100 enrolled
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Recruiting·UUniversity of Edinburgh·Phase 2/3·NCT04302870·1,150 enrolled
Vascular Trial Associated Registry Pilot
Recruiting·CCorewell Health West·Phase 4·NCT07076082·350 enrolled
Control Crohn Safe Trial
Recruiting·MMaastricht University Medical Center·Phase 4·NCT03917303·158 enrolled
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
Recruiting·GGlobal Coalition for Adaptive Research·Phase 2·NCT05948553·200 enrolled
Page 1 of 55

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)